PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
10-May-2023 Impact Shine Communications rolls in to advance Life Science Business and Marketing Strategies Impact Shine Communications Ltd
10-May-2023 Impact Shine Communications rolls in to advance Life Science Business and Marketing Strategies Impact Shine Communications Ltd
02-May-2023 Lumea and OptraSCAN Announce Partnership to Enable Seamless Adoption of Digital Pathology OptraSCAN Inc
14-Apr-2023 The PM Society Digital Awards 2023 are Open for Entries PM Society
30-Mar-2023 Tower Cold Chain secures spot in Financial Times top 1000 fastest-growing companies Tower Cold Chain
28-Mar-2023 Connect in Pharma releases report on future trends in pharma production and manufacturing Easyfairs
23-Mar-2023 Connect in Pharma releases report on future trends in pharma production and manufacturing Sciad Communications
21-Mar-2023 2023 PM Society Awards – Winners Announced PM Society
21-Mar-2023 Sustainability takes centre stage for Tower Cold Chain at LogiPharma Tower Cold Chain
16-Mar-2023 Personalised Virtual Factory Tours Highlight Risks and Solutions for Improving Pharma/Biopharma Product Safety Mettler-Toledo
06-Mar-2023 Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants BellaSeno GmbH
02-Mar-2023 Clasado expands its D2C prebiotic supplement range with Bimuno® Immunity launch Clasado Biosciences
22-Feb-2023 Pharma Targeting Celebrates 10 years of Connecting People Intelligently Pharma Targeting
08-Feb-2023 Medical futurist names three trends shaping the future of Pharma ConnectinPharma
26-Jan-2023 Cherwell publishes new guide to EM best practice in compliance with revised Annex 1 Cherwell Laboratories
26-Jan-2023 Bloomsbury Genetic Therapies Announces Orphan Drug Designations of BGT-DTDS for the Treatment of Dopamine Transporter Deficiency Syndrome Bloomsbury Genetic Therapies Limited
25-Jan-2023 Organic Acids Market is estimated to be US$ 18.6 billion by 2032 with a CAGR of 6.8% over the forecast period (2022-2032) Prophecy Market Insights
16-Jan-2023 The Scottish Medicines Consortium recommends Merck’s TEPMETKO® (tepotinib) as the first oral MET inhibitor treatment option for advanced NSCLC adult patients with METex14 skipping alterations Merck
11-Jan-2023 Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program Avance Clinical
06-Jan-2023 PM Society Training Courses – Start 2023 with some fresh education and personal development PM Society